Clinical Approach To Melanoma Detection

The seminar discusses the clinical approach to melanoma detection, emphasizing the importance of early diagnosis. Mentor Bernard Ackerman's insights from the 70s and 80s on diagnosing small, flat melanomas are highlighted, and the role of dermatoscopy in improving detection sensitivity is acknowledged. Despite nearly 100,000 melanoma cases diagnosed annually, nearly all localized, the five-year survival rate remains high at 94%. However, discrepancies arise in melanoma incidence and mortality rates, suggesting a stable occurrence of lethal forms of melanoma amidst increasing detection of early-stage lesions. The speaker notes significant overdiagnosis, where benign conditions are mistakenly classified as melanoma due to heightened clinician and patient awareness and an inclination not to miss a cancer diagnosis. The subjectivity in pathology diagnoses, especially for thin melanoma and dysplastic nevi, leads to inconsistencies, often confusing benign and malignant lesions. This overdiagnosis trend raises questions about the long-term implications of biopsies and excisions without sufficient evidence of progression from diagnosed lesions. The talk concludes with a call for increased awareness regarding overdiagnosis, suggesting that more cautious practices in biopsy decision-making and screening could help mitigate unnecessary procedures and anxiety for patients.